62 results
Page 3 of 4
10-K
6euz0lm l5gv13x
18 Mar 21
Annual report
4:25pm
8-K
EX-99.1
b8vdpngkpdu6
18 Mar 21
Results of Operations and Financial Condition
4:11pm
8-K
EX-99.1
rp395
15 Mar 21
ALX Oncology Announces Appointment of Sophia Randolph, M.D., Ph.D., to Board of Directors
8:30am
424B4
4495409g144ejhy02f
11 Dec 20
Prospectus supplement with pricing info
12:00am
DRS
sr8 q82kmgo1om
24 Nov 20
Draft registration statement
12:00am
8-K
EX-99.1
0kf4mt
12 Nov 20
ALX Oncology Reports Third Quarter 2020 Financial Results and Provides Clinical Development and Operational Highlights
4:20pm
10-Q
8ntlz3q8xxvci5m
27 Aug 20
Quarterly report
4:49pm
8-K
EX-99.1
t15yq8f8
27 Aug 20
ALX Oncology Reports Second Quarter 2020 Financial Results and Provides Operational and Clinical Highlights
4:16pm
424B4
l8zv7xn6oefiqn6
17 Jul 20
Prospectus supplement with pricing info
4:27pm
S-1
EX-10.15
1ghafa9
26 Jun 20
IPO registration
4:34pm
S-1
EX-10.14
dg0ag
26 Jun 20
IPO registration
4:34pm
S-1
EX-10.13
yn2aikc
26 Jun 20
IPO registration
4:34pm
S-1
bml4f8wnjk
26 Jun 20
IPO registration
4:34pm
DRSLTR
upfpwr
12 Jun 20
Correspondence regarding draft registration statement
12:00am
DRS/A
ootnnyd9 3w0
12 Jun 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.13
dovld
12 Jun 20
Draft registration statement (amended)
12:00am